Advertisement
Surgery
Advanced searchSave search
Original communication| Volume 83, ISSUE 2, P223-229, February 1978

Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. I. In vivo inhibition of peritoneal leukocytosis

DOI:https://doi.org/10.5555/uri:pii:0039606078902829
Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. I. In vivo inhibition of peritoneal leukocytosis
Previous ArticleNeuronal uptake of endogenous norepinephrine: A determinant of splenic but not renal vascular resistance following hemorrhage
Next ArticlePrevention of deep vein thrombosis in urological patients: A controlled, randomized trial of low-dose heparin and external pneumatic compression boots
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Sprague-Dawley rats were injected intraperitoneally with an inoculum of living or killed E. Coli suspended in a solution with or without hemoglobin. Rat mortality rate was directly proportional to both the number of viable bacteria and the amount of hemoglobin injected, though sterile hemoglobin was innocuous. Serial bacterial colony counts, white blood cell counts, and differential stains of the peritoneal fluid revealed that (1) hemoglobin significantly inhibited the intraperitoneal influx of white cells (especially polymorphonuclear leukocytes [PMNs]) in response to an intraperitoneal bacterial challenge; (2) hemoglobin inhibited bacterial clearance from the peritoneal cavity; (3) both the rate of clearance from and the rate of PMN influx into the peritoneal cavity were inversely proportional to the hemoglobin concentration; (4) hemoglobin reversed both the process of peritoneal leukocytosis and the clearance of bacteria from the peritoneal cavity when injected 90 minutes after the bacteria; (5) the suppressive effect of hemoglobin on peritoneal leukocytosis did not depend on bacterial viability. The results strongly suggest that hemoglobin interferes with the response of PMNs to chemotactic stimuli normally produced after bacterial challenge in the peritoneal cavity. Thus the adjuvant effect of hemoglobin in experimental peritonitis appears to be based on its interference with the influx of PMNs into the peritoneal cavity in response to bacterial organisms. Thus the organisms are relieved of the principal antibacterial defense in the peritoneal cavity and are permitted uncontrolled proliferation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Bornside G.H.
        • Kuebler II, W.J.
        • Cohn Jr., I.
        Enhanced bacterial virulence in fluids produced in strangulation intestinal obstruction.
        in: Proc Soc Exp Biol Med. 121. 1966: 551
        • Bornside G.H.
        • Bouis Jr., P.J.
        • Cohn Jr., I.
        Hemoglobin and Escherichia coli, a lethal intraperitoneal combination.
        J Bacteriol. 1968; 95: 1567
        • Bornside G.H.
        • Bouis Jr., P.J.
        • Cohn Jr., I.
        Enhancement of Escherichia coli infection and endotoxic activity by hemoglobin and ferric ammonium citrate.
        Surgery. 1970; 68: 350
        • Davis J.H.
        • Yull A.B.
        A possible toxic factor in abdominal injury.
        J Trauma. 1962; 2: 291
        • Davis J.H.
        • Yull A.B.
        A toxic factor in abdominal injury. II. The role of the red cell component.
        J Trauma. 1964; 4: 84
        • Filler R.M.
        • Sleeman H.K.
        • Hendry W.S.
        • et al.
        Lethal factors in experimental peritonitis.
        Surgery. 1966; 60: 671
        • Filler R.M.
        • Sleeman H.K.
        Pathogenesis of peritonitis. I. The effect of Escherichia coli and hemoglobin on peritoneal absorption.
        Surgery. 1967; 61: 385
        • Hobson D.
        • Hirsch J.G.
        The antibacterial activity of hemoglobin.
        J Exp Med. 1958; 107: 167
        • Keller H.Y.
        • Sorkin E.
        Studies on chemotaxis. V. On the chemotactic effect of bacteria.
        Int Arch Allergy. 1967; 31: 505
        • Lambert H.P.
        • Richley J.
        The action of mucin in promoting infections: The anticomplementary effect of mucin extracts and certain other substances.
        Br J Exp Pathol. 1952; 33: 327
        • Landy M.
        • Batson H.C.
        On the identity of the “virulence enhancement” factor in gastric mucin.
        J Immunol. 1949; 62: 477
        • Olitzki L.
        Mucin as a resistance-lowering substance.
        Bacteriol Rev. 1948; 12: 149
        • Sawyer W.D.
        • Kuehne R.W.
        • Cochenour W.S.
        Effect of egg yolk and phosphatides on antrax infections of rats and guinea pigs.
        in: Proc Soc Exp Biol Med. 118. 1965: 105
        • Schneierson S.S.
        • Amsterdam D.
        • Perman E.
        Enhancement of intraperitoneal staphylococcal virulence for mice with different bile salts.
        Nature. 1965; 190: 829
        • Shin H.S.
        • Snyderman R.
        • Friedman E.
        • et al.
        Cleavage of guinea pig C3 by serum-treated endotoxic lipopolysaccharide.
        in: Fed Proc. 28. 1969: 485
        • Simmons R.L.
        • Diggs J.W.
        • Sleeman H.K.
        Pathogenesis of peritonitis. III. Local adjuvant action of hemoglobin in experimental E. coli peritonitis.
        Surgery. 1968; 63: 810
        • Sleeman H.K.
        • Diggs J.W.
        • Hendry W.S.
        • et al.
        Pathogenesis of peritonitis. II. The effect of Escherichia coli and adjuvant substances on peritoneal absorption.
        Surgery. 1967; 61: 393
        • Smith H.
        • Gallop R.C.
        • Stanley J.L.
        The virulence-enhancing factor of mucins.
        Biochem J. 1952; 52: 15
        • Snyderman R.
        • Gewurz H.
        • Mergenhagen S.E.
        Interactions of the complement system with endotoxin lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.
        J Exp Med. 1968; 128: 259
        • Snyderman R.
        • Shin H.S.
        • Phillips J.K.
        • et al.
        A neutrophil chemotactic facter derived from C′5 upon inactivation of guinea pig serum with endotoxin.
        J Immunol. 1969; 103: 413
        • Steinberg B.
        Infections of the peritoneum.
        Harper and Brothers, New York1949 (chapter 2)
        • Ward P.A.
        • Cochrane C.G.
        • Muller-Eberhardt N.J.
        The role of serum complement in chemotaxis of leukocytes in vitro.
        J Exp Med. 1965; 122: 327
        • Ward P.A.
        • Cochrane C.G.
        • Muller-Eberhardt N.J.
        Further studies on the chemotactic factor of complement and its formation in vivo.
        Immunology. 1966; 11: 141
        • Whitney D.M.
        • Anigstein L.
        • Micks D.W.
        Antibacterial activity of hydrolyzed red blood cells in vitro.
        in: Proc Soc Exp Biol Med. 74. 1950: 346
        • Youmans R.
        • King T.C.
        The potentiation of bacterial contamination by hemoperitoneum.
        J Surg Res. 1964; 4: 567

      Article info

      Publication history

      Accepted: April 12, 1977

      Footnotes

      ☆Supported by United States Public Health Service grant No. AM 13083.

      ☆☆Presented at the Third Tripartite Meeting, Philadelphia, Pa., Sept. 29, 1976.

      Identification

      DOI: https://doi.org/10.5555/uri:pii:0039606078902829

      Copyright

      © 1978 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX